Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 1c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.07, $0.01 better than the analyst estimate of $0.06.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral